Total Funding
85
61
Total FundingSeries C raised
Growth Score 85 in past quarter
-8 pts
Heat Score 61 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9385
Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.
- Kathryn Kosuda: Co-founder, VP of Research & Development
Livio Valenti: Co-Founder, Senior VP of Strategy, BD and Operations
About the Company
Terrestrial Bio is developing the MIMIX™ sustained release patch technology, the easiest and most effective way to administer vaccines and therapeutics. For vaccines, the controlled release simulates the pace of a natural infection, helping the body produce a slow, strong, and enduring ramp-up of immune response, ultimately boosting a vaccine’s
effectiveness. Engineered for stability, Vaxess’s patch does not require refrigeration and can be shipped to and applied in low-resource settings.
Women Founded